Sirolimus and Mycophenolate Mofetil as Calcineurin Inhibitor-Free GVHD Prophylaxis for RIC Umbilical Cord Blood Transplantation

The use of calcineurin inhibitors (CNIs) to reduce the risk of graft-versus-host disease (GVHD) after hematopoietic cell transplantation (HCT) requires intensive post-transplant toxicity monitoring. Sirolimus-based GVHD prophylaxis is associated with a favorable toxicity profile and requires less in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Bejanyan, Nelli, Rogosheske, John, DeFor, Todd E., Lazaryan, Aleksandr, Arora, Mukta, Holtan, Shernan G., Jacobson, Pamala A., MacMillan, Margaret L., Verneris, Michael R., Blazar, Bruce R., Weisdorf, Daniel J., Wagner, John E., Brunstein, Claudio G
Format: Artigo
Idioma:Inglês
Publicat: 2016
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5067231/
https://ncbi.nlm.nih.gov/pubmed/27519278
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2016.08.005
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars